GeneSight Testing in Hickory at Catawba Valley Psychiatry and Mental Health

Tired of trial and error

We hear it all the time in the Valley: "I have tried everything and nothing works," or "Every pill makes me feel sick." Some patients have been through a half-dozen antidepressants over the years with a family doctor, a clinic in Charlotte, and a provider who moved away. That kind of history is discouraging. Genetic testing will not fix it by itself, but it can help explain some of it and make the next choice less of a guess.

What GeneSight looks at

GeneSight is a lab test made by Myriad Genetics. A provider swabs the inside of your cheek, and the lab looks for variations in genes that affect how your body handles many psychiatric medicines. Two of the genes on the panel, CYP2D6 and CYP2C19, build the liver enzymes that clear many of these pills from your body. If you break a medicine down too quickly, it may never reach a helpful level. If you break it down too slowly, side effects can stack up even at a normal dose.

Reading the results

The report puts common medicines into groups by how your genes are likely to interact with them. Some are marked as use as directed. Others are flagged for a moderate or significant gene-drug interaction, which might mean a different dose, extra monitoring, or a different first choice. Your provider will walk you through what the colors mean in plain language.

Who it helps most

Testing makes the most sense if you have tried two or more medicines for depression or anxiety without good results, had strong side effects on normal doses, or take several other medicines where interactions are a concern. If you have never tried a psychiatric medicine before, most people do fine on standard choices without testing first.

What the research says

Studies on this kind of testing are encouraging but not perfect. In a large trial called GUIDED, people whose providers used GeneSight results were more likely to respond to treatment and reach remission, although the study missed its main target for overall symptom improvement. Separate expert guidelines recommend adjusting some antidepressants for people with certain CYP2D6 and CYP2C19 results. In plain terms, it is a useful tool, not a crystal ball.

What it will not tell you

GeneSight does not diagnose depression, anxiety, or anything else. It cannot say for sure which medicine will work. Your symptoms, history, other health problems, and what matters to you still guide the decision. Your provider uses the report alongside a full psychiatric evaluation.

An everyday example

Say someone felt shaky, sick to their stomach, and wired on two different antidepressants at low doses. Their report might show that they process certain antidepressants very slowly, which can push levels higher than expected. That could point their provider toward a different medicine or a smaller starting dose. It does not make the decision for them, but it can explain why the past went the way it did.

How the process goes

First, you and your provider decide whether testing is likely to change your plan. Then a quick, painless cheek swab is collected and sent to the lab. When results come back, your provider reviews them with you and explains how they affect your options. Your genes do not change, so the results stay useful for future decisions too.

Is it worth it right now?

If you have only tried a single antidepressant for a couple of weeks, the better move is often to give it a fair trial at a proper dose before testing. If you have a long list of medicines that failed or made you sick, testing is more likely to change your plan. Your provider will tell you honestly which camp you are in, and if the test is not likely to help, they will say so.

Getting started

Testing is ordered as part of your care with us, then folded into medication management. Come see us at 520 8th St NE in Hickory, and become a patient to ask whether it is right for you.